Medi Assist Healthcare Services Ltd

AI
Medi Assist Ser. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Medi Assist Healthcare Services Ltd

₹ 350 -0.47%
13 Aug - close price
mediassist.in BSE: 544088 NSE: MEDIASSIST
About

Incorporated in June 2000, Medi Assist Healthcare Services Limited is a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies.[1]

Key Points

Business Profile:[1][2]
Company provides third-party administration (TPA) services to insurance companies through its wholly-owned Subsidiary, Medi Assist TPA. A third-party administrator is an organization that processes health insurance claims for insurance companies and provides services such as policy administration, customer service, and network management, among others.

Website BSE NSE
  • Market Cap ₹ 2,625 Cr.
  • Current Price ₹ 350
  • High / Low ₹ 576 / 293
  • Stock P/E 26.6
  • Book Value ₹ 112
  • Dividend Yield 0.57 %
  • ROCE 14.1 %
  • ROE 13.9 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 4.61%
  • Tax rate seems low
  • Dividend payout has been low at 14.4% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Financial Services Financial Services Insurance Insurance Distributors

Part of BSE Insurance BSE Financial Services BSE 1000

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
136 141 166 167 168 181 186 189 191 233 240 242 237
105 118 132 130 132 142 146 148 149 193 195 194 189
Operating Profit 31 22 34 37 35 38 40 41 42 40 45 48 48
OPM % 23% 16% 20% 22% 21% 21% 21% 22% 22% 17% 19% 20% 20%
2 5 4 4 5 6 4 8 7 2 -7 3 10
Interest 1 1 1 1 2 2 2 4 5 8 8 2 2
Depreciation 8 8 11 12 14 14 14 14 14 21 21 21 22
Profit before tax 23 18 26 28 25 30 27 30 31 13 8 28 35
Tax % 32% 3% 17% 9% 24% 29% -10% 28% 26% 40% 51% -95% 21%
16 18 21 26 19 21 30 22 23 8 4 54 28
EPS in Rs 2.30 2.58 2.98 3.58 2.68 2.99 4.19 3.05 3.18 1.13 0.56 7.16 3.71
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
277 319 323 394 505 635 723 905 951
194 237 247 302 385 501 569 730 770
Operating Profit 82 82 76 92 120 133 154 175 181
OPM % 30% 26% 23% 23% 24% 21% 21% 19% 19%
-14 7 11 21 12 -5 24 5 9
Interest 4 4 6 3 3 3 10 23 20
Depreciation 23 27 32 28 27 43 56 77 85
Profit before tax 41 59 49 81 102 82 112 80 85
Tax % 37% 41% 47% 21% 28% 16% 18% -11%
26 35 26 64 74 69 92 89 94
EPS in Rs 7,254.85 9,576.18 7,064.52 9.33 10.76 9.53 12.89 11.78 12.56
Dividend Payout % 0% 0% 0% 20% 18% 26% 0% 17%
Compounded Sales Growth
10 Years: %
5 Years: 23%
3 Years: 21%
TTM: 27%
Compounded Profit Growth
10 Years: %
5 Years: 32%
3 Years: 11%
TTM: 5%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -37%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 16%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.04 0.04 0.04 34 34 35 35 37
Reserves 218 212 290 303 342 437 506 802
98 115 35 27 31 26 204 54
202 231 220 238 295 344 412 479
Total Liabilities 518 558 545 602 702 842 1,158 1,372
142 138 119 99 171 246 306 659
CWIP 3 1 1 6 0 3 4 0
Investments 88 72 111 201 44 77 274 158
285 347 315 296 487 516 574 556
Total Assets 518 558 545 602 702 842 1,158 1,372

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
35 19 139 64 81 66 138 118
-21 -22 -61 -83 -10 -55 -218 -160
-10 -12 -10 -30 -32 -15 112 12
Net Cash Flow 4 -15 69 -49 39 -3 32 -30
Free Cash Flow 14 -2 126 62 53 49 92 62
CFO/OP 97% 70% 141% 116% 100% 70% 89% 68%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 119 78 137 110 92 103 112 116
Inventory Days
Days Payable
Cash Conversion Cycle 119 78 137 110 92 103 112 116
Working Capital Days -80 -103 -73 -59 -66 -43 -105 25
ROCE % 20% 19% 23% 26% 23% 19% 14%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Group Premiums Under Management (PUM)
INR Crore ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Retail Premiums Under Management (TPA Model)
INR Crore ・Standalone data
Corporate Accounts (Group Customers)
Number ・Standalone data
Group PUM Retention Rate (annual renewal basis)
% ・Standalone data
Group Segment Market Share (Health Insurance Premiums)
% ・Standalone data
Group+Retail Market Share (Health Insurance Premiums)
% ・Standalone data
Hospital Network (Pan-India)
Number of hospitals ・Standalone data
Claims Processed (IP + OP)
Lakh ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
38.91% 38.85% 20.60% 20.56% 20.56% 20.55% 4.87% 4.62% 4.61% 4.61%
9.67% 9.76% 16.25% 14.04% 13.26% 13.89% 23.00% 25.27% 24.31% 25.42%
30.60% 29.18% 41.33% 42.72% 42.91% 42.30% 48.90% 49.91% 49.18% 47.24%
20.80% 22.21% 21.83% 22.68% 23.25% 23.27% 23.24% 20.19% 21.90% 22.74%
No. of Shareholders 92,83378,44588,20395,87199,9841,02,99198,80593,18188,97088,148

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls